RxDoctor Payments Data

Ieshsa Engle, NP

Family · Richmond, INNPI 1740753946

Payments from drug & device makers

$4,669in general payments, 2019–2025

Across 270 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$643
  • Astellas Pharma US Inc$357
  • Pfizer$335
  • Daiichi Sankyo Inc.$307
  • Eisai Inc.$268
  • Merck$264
  • plus $2K from 43 others

What the payments were for

  • Food & beverage$3,86383%
  • Education$80617%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,669 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$55,456
Medicare patients
278
Services billed
1,072

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MekinistTrametinib Dimethyl Sulfoxide11$170,774
TafinlarDabrafenib Mesylate11$159,982
EliquisApixaban42$35,641
Exemestane20$1,780
Hydroxyurea21$739
Letrozole26$566
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$450
Ondansetron OdtOndansetron18$449
Anastrozole11$355
Prochlorperazine Maleate15$254
Levothyroxine Sodium14$235
Sucralfate14$194
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$154
Pantoprazole Sodium16$153
Triamcinolone Acetonide14$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisMekinist, Tafinlar$643$330,75722 claims
PfizerEliquis$335$35,64142 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.

Other family in Richmond

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →